DevaCell DEVA (Designer Encapsulated Viral Assembly) approach for the first time provides the highest level of flexibility for viral vector design for viral-vector based therapeutics. The core innovation is the breakthrough virus surface engineering technology ONCoat, which can be applied to a variety of viruses.

ONCoat is an organic/inorganic hybrid chemistry that makes virus essentially stealth to the immune system by blocking access of antibodies to the virus surface and preventing neutralization of the virus ONCoat dramatically improves the pharmacokinetics enabling tissue specific systemic delivery with unprecedent efficiency with powerful tissue specific targeting capability without reducing the infectivity of the virus.

Combined with synergistic genetic modifications to the virus, DevaCell achieves best-in-class viral therapeutics.